IDEAYA Biosciences to Participate in Upcoming April 2023 Investor Relations Event

SOUTH SAN FRANCISCO, Calif., April 3, 2023 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in upcoming investor relations event(s). Cantor’s The…